Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Garry A. Nicholson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeremy Bender - $321K in DAWN purchases and sales in the last 12 months
- Lynx1 Capital Management LP - $146K in TCRX purchases and sales in the last 12 months
- Adam Dubow - $113K in DAWN purchases and sales in the last 12 months
- Charles N. York II - $107K in DAWN purchases and sales in the last 12 months
- Lauren Merendino - $101K in DAWN purchases and sales in the last 12 months
- Michael Vasconcelles - $32K in DAWN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Garry A. Nicholson?
Garry A. Nicholson is a corporate insider of TScan Therapeutics, Inc. (TCRX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Garry A. Nicholson last file a Form 4?
The most recent primary Form 4 on record is dated 22 May 2026, one of 4 filings going back to 2025.
